[go: up one dir, main page]

AU2002217010A1 - Peptides, the production and use thereof for binding immunoglobulins - Google Patents

Peptides, the production and use thereof for binding immunoglobulins

Info

Publication number
AU2002217010A1
AU2002217010A1 AU2002217010A AU1701002A AU2002217010A1 AU 2002217010 A1 AU2002217010 A1 AU 2002217010A1 AU 2002217010 A AU2002217010 A AU 2002217010A AU 1701002 A AU1701002 A AU 1701002A AU 2002217010 A1 AU2002217010 A1 AU 2002217010A1
Authority
AU
Australia
Prior art keywords
peptides
production
binding immunoglobulins
immunoglobulins
binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002217010A
Inventor
Ralf Egner
Rudolf Kunze
Wolfgang Ronspeck
Dirk Winkler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AFFINA IMMUNTECHNIK GmbH
Original Assignee
AFFINA IMMUNTECHNIK GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AFFINA IMMUNTECHNIK GmbH filed Critical AFFINA IMMUNTECHNIK GmbH
Publication of AU2002217010A1 publication Critical patent/AU2002217010A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Peptides having the following amino acid sequence as well as peptides or proteins which contain this amino acid seque
AU2002217010A 2000-11-08 2001-11-08 Peptides, the production and use thereof for binding immunoglobulins Abandoned AU2002217010A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00124418.5 2000-11-08
EP00124418 2000-11-08
PCT/EP2001/012933 WO2002038592A2 (en) 2000-11-08 2001-11-08 Peptides, the production and use thereof for binding immunoglobulins

Publications (1)

Publication Number Publication Date
AU2002217010A1 true AU2002217010A1 (en) 2002-05-21

Family

ID=8170325

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002217010A Abandoned AU2002217010A1 (en) 2000-11-08 2001-11-08 Peptides, the production and use thereof for binding immunoglobulins

Country Status (7)

Country Link
US (1) US7205382B2 (en)
EP (1) EP1332158B1 (en)
AT (1) ATE368688T1 (en)
AU (1) AU2002217010A1 (en)
DE (1) DE50112802D1 (en)
ES (1) ES2292638T3 (en)
WO (1) WO2002038592A2 (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6916904B2 (en) * 2002-04-24 2005-07-12 Zolaris Biosciences, Llc Inhibition of immune complex formation
CA2497254A1 (en) 2002-09-06 2004-03-18 Forschungsverbund Berlin E. V. Akap18 delta, a novel splicing variant of a protein kinase a anchor protein and the use of the same
EP1730170B1 (en) 2004-03-10 2020-02-19 Trinity Therapeutics, Inc. Method for inhibiting immune complex formation in a subject
EP1754715A1 (en) 2005-08-19 2007-02-21 Bundesrepublik Deutschland vertreten durch das Bundesminsterium für Gesundheit, dieses vertr. durch das Robert-Koch-Institut Vaccine on the basis of virus-neutralising antibodies
US20080207498A1 (en) * 2005-09-06 2008-08-28 Bodie Neil M Methods for Treating Alzheimer's Disease
EP1832600A1 (en) 2006-03-09 2007-09-12 Max-Delbrück-Centrum Für Molekulare Medizin Peptides against autoantibodies associated with glaucoma and use of these peptides
GB0620200D0 (en) * 2006-10-11 2006-11-22 E2V Biosensors Ltd Conjugates for use in analyte detection
DE102007004909A1 (en) 2007-01-26 2008-07-31 Ga Generic Assays Gmbh Use of pancreatic zymogen granule polypeptide GP2 as a medicament, especially for treating autoimmune diseases by plasmapheresis
EP2080519A1 (en) 2008-01-15 2009-07-22 Max-Delbrück-Centrum für Molekulare Medizin (MDC) Peptides having binding affinity to an antibody which recognizes an epitope on an alpha1 loop 2 or beta 2 loop 1 of an adrenoreceptor
WO2010009380A2 (en) * 2008-07-18 2010-01-21 Trinity Therapeutics, Inc. Methods for treating immune-mediated dengue fever infections and antibody-dependent enhancement of dengue fever infections, including dengue hemorrhagic fever and dengue shock syndrome
EP2172481B1 (en) 2008-10-06 2014-10-29 Novoplant GmbH Proteolytically stable antibody formats
EP2199305A1 (en) 2008-12-18 2010-06-23 Max-Delbrück-Centrum Peptides against autoantibodies associated with CRPS and use of these peptides
KR101606236B1 (en) 2009-08-19 2016-03-24 메르크 파텐트 게엠베하 Antibodies for the detection of integrin complexes in ffpe material
EP2742065B1 (en) 2011-08-12 2017-08-02 E.R.D.E.-aak-Diagnostik Gmbh Agonistic autoantibodies to the alpha1-adrenergic receptor and the beta2-adrenergic receptor in alzheimer's and vascular dementia
CN103890174B (en) * 2011-08-24 2015-12-23 大塚化学株式会社 IgG-binding peptide and method for detecting and purifying IgG using same
EP2913675B1 (en) 2014-02-28 2020-02-12 GA Generic Assays GmbH GP2 isoforms and their use in autoantibody capture
CA2940579A1 (en) 2014-03-13 2015-09-17 Universitaet Basel Carbohydrate ligands that bind to igm antibodies against myelin-associated glycoprotein
WO2017046172A1 (en) 2015-09-16 2017-03-23 Universität Basel Carbohydrate ligands that bind to antibodies against glycoepitopes of glycosphingolipids
WO2017069269A1 (en) * 2015-10-23 2017-04-27 富士フイルム株式会社 Cyclic peptide, affinity chromatography support, labeled antibody, antibody-drug conjugate, and pharmaceutical preparation
CA3000979A1 (en) * 2015-10-23 2017-04-27 Fujifilm Corporation Cyclic peptide, affinity chromatography support, labeled antibody, antibody-drug conjugate, and pharmaceutical preparation
WO2017209471A1 (en) * 2016-05-30 2017-12-07 동국대학교 산학협력단 Affinity ligand for antibody purification, having high antibody binding capacity and mild elution condition, and use thereof
EP3299818B1 (en) 2016-09-26 2019-12-04 GA Generic Assays GmbH Method for the diagnosis of acute pancreatitis (ap) by detection of glycoprotein 2 isoform alpha (gp2a)
CN109790202B (en) * 2016-09-30 2022-09-13 富士胶片株式会社 Cyclic peptide, affinity chromatography carrier, labeled antibody, antibody drug complex and pharmaceutical preparation
WO2019015814A1 (en) 2017-07-20 2019-01-24 Ga Generic Assays Gmbh Chitinase-3-like protein 1 (chi3l1) as an autoantigen in autoimmune disorders of the digestive system
EP3669888B1 (en) 2018-12-20 2025-09-24 Gambro Lundia AB Extracorporeal devices for methods for treating diseases associated with anti-neutrophil cytoplasmic antibodies
WO2020127968A1 (en) 2018-12-20 2020-06-25 Marino Stephen F Protein-drug conjugate comprising a monomeric form of proteinase 3
WO2021018758A1 (en) 2019-07-26 2021-02-04 Technische Universität Dresden Device for extracorporeal lowering of asymmetric dimethylarginine and monomethyl arginine levels in human blood

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1086955A1 (en) * 1999-09-21 2001-03-28 Affina Immuntechnik GmbH Peptides against antibodies elicited by DCM
DE60041564D1 (en) 1999-12-24 2009-03-26 Genentech Inc Methods and compositions for extending the disposal half-life of bioactive compounds

Also Published As

Publication number Publication date
US20040087765A1 (en) 2004-05-06
DE50112802D1 (en) 2007-09-13
WO2002038592A2 (en) 2002-05-16
ES2292638T3 (en) 2008-03-16
WO2002038592A3 (en) 2003-01-23
EP1332158A2 (en) 2003-08-06
EP1332158B1 (en) 2007-08-01
ATE368688T1 (en) 2007-08-15
US7205382B2 (en) 2007-04-17

Similar Documents

Publication Publication Date Title
AU2002217010A1 (en) Peptides, the production and use thereof for binding immunoglobulins
NZ521396A (en) Fusion proteins comprising two or more Neisseria polypeptides
WO2003011115A3 (en) Peptide-based multimeric targeted contrast agents
WO2003052054A3 (en) Bgl5 beta-glucosidase and nucleic acids encoding the same
WO2003027306A3 (en) Bgl3 beta-glucosidase and nucleic acids encoding the same
WO2003020932A1 (en) Novel secretory proteins and dna thereof
HK1044966A1 (en) C-terminal protein tagging
WO2003074546A3 (en) Streptavidin-binding peptide
IL172729A0 (en) Reagents and methods for the formation of disulfide bonds and the glycosylation of proteins
CA2361987A1 (en) Goodpasture antigen binding protein
AU2002365269A1 (en) Mut-il-18 or mut-il-18r proteins, antibodies, compositions, methods and uses
AU2001238064A1 (en) 18477, a human protein kinase and uses therefor
AUPP627498A0 (en) Novel peptides - i
MXPA04002103A (en) A caspase- 8 binding protein, its preparation and use.
WO2001059120A3 (en) Il-17 like molecules and uses thereof
WO2006127822A3 (en) Scytovirin domain 1 related polypeptides
WO2001002429A3 (en) Angiopoietin-6 and uses thereof
EP0816498A3 (en) Excitatory amino acid receptor protein and related nucleic acid compounds
AU2002220924A1 (en) Antibodies, peptides, analogs and uses thereof
WO2001092468A3 (en) Novel compositions for the expression of the human peptide histidine transporter 1 and methods of use thereof
AU2003295435A1 (en) Biological carriers for the delivery of proteins or peptides
WO2001087932A3 (en) Seven transmembrane proteins and polynucleotides encoding the same
WO2002088168A3 (en) Codon-optimised nucleic acid coding for apoaequorin and uses thereof
AU2002365925A1 (en) Rsv proteins, antibodies, compositions, methods and uses
AU759012C (en) Amino acid sequence